CONLEY, GREGORY P.,SEXTON, DANIEL J.,NIXON, ANDREW
申请号：
CA2942713
公开号：
CA2942713A1
申请日:
2015.03.26
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
Disclosed herein are compositions comprising one or more antibodies that specifically bind active plasma kallikrein (e.g., human plasma kallikrein) and methods of using such compositions for the treatment of retinal diseases, such as diabetic macular edema.
